If it wasn't for program costs, oncologists participating in the Oncology Care Model compared with those who did not found that the first year of the program was associated with less physician-administered drug use in prostate cancer, lower drug costs in lung and prostate cancer, fewer visits for patients with breast or colon cancer, and...
